Clinical profile and response to oral prednisolone in infantile spasm.
OBJECTIVE
To evaluate the clinical profile and response to oral prednisolone in infantile spasms.


METHODS
Case series.


METHODS
Neurology Department, The Children Hospital and Institute of Child Health, Multan, from July 2005 to June 2007.


METHODS
Fifty patients of infantile spasms were studied. Age, gender, age at onset of seizures, type of spasms (flexor, extensor or mixed), history of intrapartum asphyxia, developmental history, dysmorphic facial features, any hypopigmented/ hyperpigmented skin lesions, computed tomogram and electroencephalogram findings and response to oral prednisolone was noted. Data was analyzed statistically by SPSS 10. Descriptive statistics was used to find out frequencies and percentages of all above mentioned variables. Chi-square test was applied to determine the association between these variables and response to treatment. P-value of less than 0.05 was taken significant.


RESULTS
Male to female ratio was 2.1:1. Mean age of babies was 6.5+/-3.35 months. Mean age at onset of seizures was 5.35+/-3.52 months. Flexor spasms was seen in 32 (64%), extensor spasms in 8 (16%) and mixed spasms in 10 babies (20%). Symptomatic infantile spasms were noted in 48 (96%) babies while two babies (4%) were having cryptogenic infantile spasm. History of intrapartum asphyxia was noted in 54% of symptomatic cases. Favourable response to oral prednisolone was seen in 27 babies (54%). Except male gender, none of the other variable reached the statistical significance for favourable response to treatment.


CONCLUSIONS
Infantile spasms were found more common in males, flexor spasms were the commonest type noted. Symptomatic spasm was noted in 96% of cases and intrapartum asphyxia was the commonest cause of symptomatic group. Response to oral prednisolone was noted in more than half of cases of infantile spasms.
Noureen
Nuzhat
N
Department of Neurology, Children Hospital Complex, Multan. drnuzhatrana321@gmail.com
Rana
Muhammad Tariq
MT
D004569:Electroencephalography; D005260:Female; D005938:Glucocorticoids / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007223:Infant; D008297:Male; D011239:Prednisolone / Q000008:administration & dosage / Q000627:therapeutic use*; D013035:Spasm / Q000188:drug therapy* / Q000209:etiology; D014057:Tomography, X-Ray Computed
D005938:Glucocorticoids; D011239:Prednisolone